« Return to News | Awards & Advancement

Chiltern names new senior clinical research physicians

Wednesday, February 1, 2012 03:40 PM

Global CRO Chiltern International has hired widely-published Drs. Marcelo Piccirillo and Carlo Lanza, bringing expertise in gastroenterology, oncology and pediatrics to Chiltern.

Marcelo Piccirillo, M.D., will be senior clinical research physician based out of the Wilmington, N.C., office, with special emphasis in developing the gastroenterology therapeutic area. Piccirillo has 20 years experience in the medical and clinical research industry, including seven years as a general and colorectal surgeon. His extensive clinical research therapeutic experience includes gastroenterology, pulmonary (asthma/COPD), oncology, neurology, diabetes, metabolic disease, drug safety and medical monitoring of clinical trials.

Carlo Lanza, M.D., will be senior clinical research physician based out of the Milan, Italy, office, to support and expand global activities in the oncology, hematology and pediatric therapeutic areas. Lanza has over 20 years of clinical research experience, including more than 10 years in academic medicine and clinical practice. Lanza has served in extensive medical lead roles at large pharma companies and international organizations in oncology, hematology, pediatrics and malaria R&D at a global level.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.